Delpharm, a CDMO, has inaugurated a new sterile filling line at its Saint-Rémy site to enhance France’s initiatives and strategic investments in its industrial sites. Delpharm has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line, significantly increasing its production capacity for sterile vials or freeze-drying with an additional capacity of 45 million units in 2 ml format. This investment including the new building is valued at €37 m...